Target intelligence / Profile preview

ATM interactor protein (ATMIN)

Target
ATMIN
Molecular classification
Zinc finger protein, Transcription factor, DNA damage response regulatory protein
01

Overview

ATM interactor protein (ATMIN) is a zinc finger-containing regulatory protein that acts as an essential cofactor for the checkpoint kinase ATM (axia telangiectasia mutated), orchestrating a subset of ATM-dependent DNA damage response pathways[1][2]. Unlike NBS1, which mediates ATM activation after DNA double-strand breaks, ATMIN specifically regulates ATM activation in response to non-DSB stresses such as replication stress, hypotonic stress, and DNA replication inhibitors, thereby defining an NBS1-independent ATM signaling route[1][2]. ATMIN directly interacts with ATM and both proteins mutually stabilize each other[1]. ATMIN is required to recruit DNA damage effectors such as 53BP1 at sites of replication-induced lesions and to enable phosphorylation of key ATM targets (KAP1, p53, SMC1) after such stress[2]. Loss of ATMIN impairs the cell’s ability to respond to replication stress and leads to chromosomal instability[2]. It is also known by several aliases including ASCIZ, indicating its function as a Chk2-interacting zinc finger protein and its role in ATM/ATR-related pathways, but current evidence supports its primary role as a regulatory factor rather than as a traditional drug target such as a receptor, enzyme, or transporter[1][2].

Other names
ASCIZKIAA0431ZNF822ATM/ATR-substrate Chk2-interacting zinc finger proteinzinc finger protein 822ATM/ATR-substrate CHEK2-interacting zinc finger proteinATM INteracting protein
02

Biological functions

Regulation of ATM kinase activityDNA damage response (specifically NBS1-independent ATM activation)Maintenance of chromatin integrity during replication stressRegulation of cell cycle checkpoints after stress
03

Disease associations

Cancer (impaired DNA damage signaling and chromosomal instability are risk factors)Genomic instability-related disorders

Beyond the preview

Go deeper on ATM interactor protein (ATMIN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATM interactor protein (ATMIN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call